Further information

Further information regarding Caphosol®
For all requests concerning medical device vigilance and medical information please email infomed@ΕUSAPharma.com

Contact via email:

France: caphosol-france@ΕUSAPharma.com
The Netherlands: caphosol-netherlands@ΕUSAPharma.com
Belgium: caphosol-belgium@ΕUSAPharma.com
Luxembourg: caphosol-luxembourg@ΕUSAPharma.com
Poland: caphosol-poland@ΕUSAPharma.com
CEE: caphosol-cee@ΕUSAPharma.com
Spain: Vifor-Uriach Pharma. caphosol-spain@ΕUSAPharma.com
Italy: caphosol-italy@ΕUSAPharma.com
UK: caphosol-uk@ΕUSAPharma.com
Ireland: caphosol-ireland@ΕUSAPharma.com
Germany: caphosol-germany@ΕUSAPharma.com
Austria: caphosol-austria@ΕUSAPharma.com
Switzerland: caphosol-switzerland@ΕUSAPharma.com
Portugal: caphosol-portugal@ΕUSAPharma.com
Nordic: caphosol-nordics@ΕUSAPharma.com
USA: caphosol-us@ΕUSAPharma.com
Rest of World: caphosol-restofworld@ΕUSAPharma.com
Other: caphosol-other@ΕUSAPharma.com

Caphosol

This website contains information about Oral Mucositis and the use of Caphosol for the prevention and treatment of Oral Mucositis
Caphosol is a class I medical device, marked CE

©EUSA Pharma (Europe) Ltd. May 2009. All rights reserved. www.eusapharma.com
Registered in England 4555273 Registered Office The Magdalen Centre, Oxford Science Park, Oxford OX4 4GA Vat Registration No: 896 1192 88

www.caphosol.eu